Skin Autofluorescence, as a Measure of AGE Accumulation in Individuals Suffering from Chronic Plaque Psoriasis

Table 2

Characteristics of patients with chronic plaque psoriasis.

Characteristic	PsV ()	PsV type I ()	PsV type II ()	PsV with elevated CRP ()	PsV with increased ESR ()	PsV with borderline LDL ()	PsV with prediabetes ()	Controls ()
Age mean ± SD (years)	49.33 ± 17.95	42.92 ± 16.13	63.55 ± 11.93	54.79 ± 18.96	54.43 ± 16.38	52.50 ± 13.21	57.95 ± 11.55	47.05 ± 13.93
Male (%)/; female (%)	35 (50%); 35 (50%)	24 (48.97%); 25 (51.03%)	11 (52.39%); 10 (47.61%)	10 (52.63%); 9 (47.37%)	16 (47.05%); 18 (52.95%)	7 (43.75%); 9 (56.25%)	10 (47.61%); 11 (52.39%)	29 (49.1%); 30 (50.8%)
PASI mean ± SD	10.85 ± 7.07	11.02 ± 6.43	10.44 ± 7.021	11.88 ± 5.98	10.92 ± 5.832	10.02 ± 4.457	10.46 ± 4.4
BSA mean ± SD (%)	23.39 ± 15.94	23.80 ± 13.15	22.40 ± 16.44	25.25 ± 16.06	23.38 ± 14.33	17.98 ± 13.09	18.44 ± 10.52
BMI mean ± SD	26.12 ± 3.39	25.88 ± 3.66	26.68 ± 2.656	27.89 ± 2.031	27.16 ± 3.06	26.77 ± 2.662	28.33 ± 1.57
CRP mean ± SD (mg/dl)	5.96 ± 9.79	4.63 ± 5.25	9.086 ± 15.80	15.45 ± 15.52	9.04 ± 12.54	6.306 ± 8.143	5.473 ± 4.751
ESR mean ± SD (mm)	16.83 ± 13.89	13.50 ± 9.39	24.35 ± 19.51	23.28 ± 18.57	26.13 ± 14.44	15.77 ± 9.339	22.76 ± 11.70
LDL mean ± SD (mg/dl)	108.30 ± 28.85	106.0 ± 27.97	113.7 ± 30.82	114.9 ± 23.54	108.5 ± 29.24	147.4 ± 7.164	117.8 ± 26.65
HbA1c mean ± SD (%)	5.38 ± 0.47	5.297 ± 0.446	5.579 ± 0.46	5.6 ± 0.59	5.49 ± 0.55	5.453 ± 0.151	5.94 ± 0.226
SAF mean ± SD	1.89 ± 0.59	1.665 ± 0.391	2.431 ± 0.638	2.037 ± 0.446	2.059 ± 0.52	2.093 ± 0.59	2.213 ± 0.526	1.816 ± 0.38

PsV: patients with chronic plaque psoriasis.